Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (237 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
40.76
4,67,870
74.57
1,69,316
29.77
1,15,477
22.62
1,15,062
21.44
1,11,661
54.95
1,05,107
24.35
1,02,156
36.89
88,266
184
71,821
28.84
66,393
46.33
64,556
38.17
59,527
42.05
48,324
40.80
42,688
40.15
41,590
46.66
34,201
145
30,901
123
23,818
37.61
22,380
29.71
20,899
32.46
20,112
107
20,065
51.21
19,869
890
18,895
51.81
17,033
13.50
16,939
24.04
16,538
53.91
14,014
68.32
12,648
30.63
12,320
93.83
12,117
41.53
12,104
66.32
11,756
34.78
11,371
40.86
10,539
41.02
10,468
57.72
9,980
43.78
9,717
17.42
9,686
-
9,645
4.92
8,121
25.36
7,860
24.02
6,869
330
6,692
39.10
5,786
121
5,487
39.70
5,353
40.86
4,833
34.98
4,817
-
4,745
16.85
4,260
86.58
4,042
61.61
3,890
19.65
3,831
21.56
3,638
41.38
3,625
-
3,475
50.44
3,332
43.31
2,917
60.41
2,506
176
2,460
24.22
2,405
-
2,328
7.16
2,298
37.38
2,072
48.58
2,034
64.06
1,996
45.88
1,910
26.38
1,753
48.43
1,644
26.85
1,544
34.75
1,497
67.18
1,456
21.02
1,395
17.70
1,354
22.52
1,296
16.59
1,268
59.07
1,255
74.91
1,231
28.08
1,223
13.56
1,202
26.98
1,200
885
1,035
42.85
1,006
37.55
985
58.40
936
23.39
869
47.04
835
27.30
798
19.43
798
28.17
783
31.80
671
115
660
43.36
654
21.33
635
31.16
566
48.81
542
25.25
508
27.94
497
13.84
481
22.90
457
89.31
413
-
395
70.30
349
-
341
30.65
326
33.66
325
24.52
322
58.05
322
16.28
311
64.72
292
-
290
31.46
285
124
260
-
251
13.33
237
12.22
235
21.18
227
10.74
225
-
221
44.62
220
55.22
219
-
214
13.15
213
8.31
206
11.59
205
38.28
194
64.61
193
-
186
19.05
184
26.38
175
660
171
14.39
169
16.84
165
12.51
163
10.31
159
13.90
156
20.69
154
41.83
151
-
151
9.65
145
22.05
137
27.11
137
38.80
133
19.16
132
92.22
131
20.96
130
68.07
123
13.96
122
29.73
122
29.67
118
-
116
-
114
26.83
110
26.24
106
21.77
105
18.22
105
12.00
101
87.50
93
12.74
88
37.59
88
7.60
87
22.19
86
149
81
-
80
-
72
-
72
21.00
71
-
68
15.41
65
33.40
64
3.61
63
14.80
57
17.26
54
19.40
54
-
52
33.63
52
10.52
52
5.20
47
19.48
45
-
44
-
44
99.65
44
-
43
-
42
-
42
91.66
41
464
39
-
38
9.44
37
23.75
37
-
35
17.12
35
5.41
35
13.10
32
53.56
32
12.86
32
-
31
-
31
23.71
29
-
28
7.79
27
4.60
27
12.35
27
8.62
26
19.38
25
29.81
25
-
24
-
23
-
22
27.36
21
38.32
20
77.38
19
31.38
18
-
18
3,503
18
-
17
136
16
-
13
-
13
157
12
-
12
17.15
12
27.74
12
26.50
11
7.11
11
-
8
-
8
-
8
89.76
7
75.63
7
-
6
-
5
-
4
69.81
4
-
4
-
2
Showing 5 237 of 237 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Capacity Utilization - Benzimidazole (%)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material